Diagnostic criteria for metabolic syndrome: caucasians versus African-Americans

Stacey A Zeno1, Patricia A Deuster, Jennifer L Davis

  • 1Departments of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.

Insights

Current metabolic syndrome definitions may miss at-risk African Americans. Including body fat percentage and fitness levels could improve early cardiovascular disease risk identification in this population.

Area of Science:

  • Cardiovascular disease research
  • Metabolic health and risk assessment
  • Ethnic health disparities

Background:

  • Metabolic syndrome identifies individuals at high risk for cardiovascular disease (CVD).
  • African Americans (AA) exhibit higher CVD prevalence and mortality than Caucasians (CA).
  • Early CVD diagnosis is crucial for AA, necessitating accurate metabolic syndrome classification.

Purpose of the Study:

  • To evaluate metabolic syndrome classification in healthy AA and CA using two different definitions.
  • To assess the impact of cardiovascular disease risk factors (CRP, body fat, fitness, insulin resistance, non-HDL-C) on metabolic syndrome classification across ethnic groups.

Main Methods:

  • Healthy AA (n=97) and CA (n=51) aged 18-45 without hypertension or diabetes were assessed.
  • Measurements included cardiorespiratory fitness, body composition, anthropometrics, blood pressure, and fasting blood markers (glucose, insulin, lipids, CRP).
  • Participants were classified using National Cholesterol Education Program Adult Treatment Panel III 2004 (NCEP ATP III) and International Diabetes Federation (IDF) criteria.

Main Results:

  • Significant ethnic differences in metabolic syndrome classification were observed for both NCEP ATP III (CA 16.7% vs. AA 5.7%) and IDF (CA 23.5% vs. AA 8.2%) definitions (P < 0.01).
  • These ethnic disparities in classification were eliminated when fitness level or percent body fat was incorporated as a criterion.

Conclusions:

  • Existing metabolic syndrome definitions may fail to identify healthy AA at risk for CVD.
  • Assessing percent body fat and regular exercise participation is recommended for better risk identification in AA.
  • Incorporating these factors can aid healthcare providers in the early recognition and management of CVD risk in African Americans.
Abstract

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.